You searched for "intracameral"

625 results found

Moorfields medical retina: design thinking and service delivery of intravitreal injection service

The Medical Retina service is constantly evolving and developing due to a rise in disease prevalence and treatment evolution. This unique course is especially designed for managers and clinical leaders in medical retina services. The course draws on the strength...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

Dr Sohaib Rufai awarded European Award in Medicine for Ophthalmology

Dr Sohaib Rufai has been awarded the 2022 European Award in Medicine for Ophthalmology. He led the world’s first study using handheld OCT to predict future vision in infantile nystagmus.

CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals

CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals. The seminar is to be hosted by CHEC Clinical Director Mahmoud Rabie and follows the UK rollout of CHEC’s ground-breaking YAG Quantel Capsulo Laser System which significantly improves accuracy in eye treatments.

OKKO Health announce collaboration with the University of Plymouth to measure vision in extreme environments including space

OKKO Health, a leader in innovative eye health technology, is excited to announce its collaboration with the University of Plymouth. This groundbreaking project will test eye health and track early disease detection in extreme environments, beginning with the depths of a cave and soon to monitor astronauts’ vision in the vastness of space.

The impact of obstructive sleep apnoea monitoring functionality on smartwatches: a new frontier for ophthalmologists

Dawn of a new era in wearable technology? Smartwatches have really stepped up their game and have evolved from telling time to keeping an eye on our health. In February 2024, the United States Food and Drug Administration (FDA) gave...

The challenge of chorioretinal folds in virtual eye clinics

Chorioretinal or choroidal folds are parallel striations involving the retina, retinal pigment epithelium (RPE), Bruch’s membrane, and inner choroid [1]. They can arise from compressive stress on these layers, and their presence often serves as a diagnostic marker for underlying...

OCTA use in CNV associated with CSR

The aim of this study was to assess the rate of choroidal neovascularisation (CNV) in chronic central serous chorioretinopathy (CSR) patients with flat irregular pigment epithelial detachments (PEDs) by optical coherence tomography angiography (OCTA). Data of all consecutive patients with...

Macular atrophy with aflibercept

The authors of this paper set out to investigate the prevalence of macular atrophy in treatment-naive patients with neovascular AMD undergoing aflibercept monotherapy (three monthly loading injections followed by subsequent treatment every two months). Case notes over a three year...

Multimodal imaging in wet AMD

This novel study set out to determine grader agreement levels of various retinal imaging techniques, commonly used in the diagnosis of wet age-related macular degeneration (AMD). Images from 52 eyes were by examined by two different observers. All images were...

Atrophy and anti-VEGF

The aim of this study was to investigate treatment factors, along with ocular and systemic factors for their association with macular atrophy (MA) incidence in eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF aflibercept or ranibizumab according to...